EUVIMEDFaigh amach EUVIMED
CrossrefCárta eolais

A double‐blind randomized controlled trial of personalized upper‐alpha neurofeedback in children with ADHD

Yuliang Wang, Ka Yi Hui, Siu Fung Lu, Qing Chuan Hannah Lui, Lawrence Ma, Suhail Theparambil Asharaf, Davis Lak, David Coghill, Patrick Ip, Tatia Mei Chun Lee, Winnie Wan Yee Tso

Journal of Child Psychology and Psychiatry · 2026-12 · 67 (12) · 1953-1964

DOI: 10.1111/jcpp.70188 ↗
AchoimreSonraí leabharliosta

Achoimre

Background Neurofeedback (NF) is a nonpharmacological approach for ADHD, but standard protocols often overlook individual EEG variability, potentially limiting efficacy. We report the first double‐blind randomized controlled trial of a session‐adaptive individualized upper‐alpha NF protocol in children with ADHD, based on individualized 1/f + alpha model. Methods Forty‐eight children (6–12 years) diagnosed with ADHD were randomized to individualized upper‐alpha NF ( n = 26) or sham feedback ( n = 22). Participants completed eight 1‐h sessions over four weeks. The primary outcome was parent‐rated ADHD symptoms on the SWAN scale, measured at baseline, post‐treatment, and follow‐up. Secondary outcomes included PedsQL, CBCL, SDQ, and neuropsychological tests. Intention‐to‐treat linear mixed‐effects models assessed Time × Condition interactions; within‐group changes were evaluated via paired t ‐tests. EEG learning was defined as the change in each session's upper‐alpha/theta‐to‐lower‐alpha ratio. Results Blinding was preserved (Bang's Index: caregivers = 0.13; staff = 0.21). In the NF group, 21/26 children (80.7%) achieved ‘learner’ status versus 36.4% in sham. Both groups showed significant reductions in ADHD symptoms post‐treatment (SWAN Total: NF, d = −0.879, p < .001; sham, d = −1.261, p < .001), with no between‐group difference ( d = −0.062, p = .881). At six months, NF maintained improvements in ADHD symptoms (SWAN Total: d = −0.713, p = .006), without superiority over sham ( d = 0.221, p = .633). Neuropsychological testing revealed NF‐specific gains in Purdue Pegboard non‐preferred hand ( d = 1.093, FDR q = .042) and faster CPT‐3 reaction time ( d = −1.210, FDR q = .025). Conclusions Personalized upper‐alpha NF produced higher EEG learning and selective motor‐speed improvements but did not outperform sham in reducing parent‐rated ADHD symptoms. Eight sessions sufficed for robust EEG modulation, yet non‐specific training effects likely drove clinical gains, indicating NF alone may not be an adequate ADHD treatment.

Eolas a oireann do do chuid oibre.

Ó thús saor in aisce agus taighde litríochta pearsanta go dtí an Research Suite iomlán.

Féach ar na taraifí →

An bhfuil gach téacs iomlán ó fhoilsitheoirí san áireamh?

Ní hea. Is ábhair éagsúla iad tagairtí bibleagrafaíocha, achoimrí agus lánthéacsanna. Braitheann fáil an lánthéacs ar an bhfoinse, Open Access agus ar na ceadúnais atá agat cheana. Ní chuireann taraif EUVIMED cearta breise foilsitheora ina n-ionad.

Féach ar na taraifí →